BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12005110)

  • 1. The preclinical observation that escitalopram possesses a faster time to onset of efficacy than citalopram.
    Håkanson R
    Pharmacol Toxicol; 2002 Jan; 90(1):3-4. PubMed ID: 12005110
    [No Abstract]   [Full Text] [Related]  

  • 2. Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model.
    Montgomery SA; Loft H; Sánchez C; Reines EH; Papp M
    Pharmacol Toxicol; 2001 May; 88(5):282-6. PubMed ID: 11393591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram: efficacy and tolerability in the treatment of depression.
    Baldwin DS
    Hosp Med; 2002 Nov; 63(11):668-71. PubMed ID: 12474611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM; Azorin JM; Despiegel N; Verpillat P
    Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction. Overview of citalopram.
    Lippa AS; Beer B; Cancro R
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):1S-3S. PubMed ID: 10507504
    [No Abstract]   [Full Text] [Related]  

  • 6. [Escitalopram: a chiral agent for treatment of depression].
    Overlack M; Davids E; Gastpar M
    Med Monatsschr Pharm; 2004 May; 27(5):148-51. PubMed ID: 15171592
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical development of citalopram.
    Willetts J; Lippa A; Beer B
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):36S-46S. PubMed ID: 10507507
    [No Abstract]   [Full Text] [Related]  

  • 8. Escitalopram: a pharmacoeconomic review of its use in depression.
    Croom KF; Plosker GL
    Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram-related visual and auditory hallucination in a non-dementia patient with depression.
    Lai CH
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E19. PubMed ID: 23224467
    [No Abstract]   [Full Text] [Related]  

  • 10. A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK.
    Wade AG; Toumi I; Hemels ME
    Curr Med Res Opin; 2005 Apr; 21(4):631-42. PubMed ID: 15899113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram intoxication.
    Yuksel FV; Tuzer V; Goka E
    Eur Psychiatry; 2005 Jan; 20(1):82. PubMed ID: 15642453
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment research of intermediate severity depression: what is useful for the routine patient?].
    MMW Fortschr Med; 2012 Feb; 154(2):69. PubMed ID: 22352257
    [No Abstract]   [Full Text] [Related]  

  • 13. Escitalopram ameliorates prolonged depression with psychotic features induced by interferon therapy for hepatitis C infection: report of 2 cases.
    Kajitani K; Kanba S
    Psychosomatics; 2013; 54(5):506-7. PubMed ID: 23845321
    [No Abstract]   [Full Text] [Related]  

  • 14. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials.
    Li H; Li T; Li G; Luo J
    Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A trial of treating depressive states with cipramil].
    Iakovlev VA; Belinskiĭ AV; Dorovskikh IV
    Voen Med Zh; 2000 Jun; 321(6):53-6. PubMed ID: 10929517
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon-induced depression treated with citalopram.
    Farah A
    J Clin Psychiatry; 2002 Feb; 63(2):166-7. PubMed ID: 11874221
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of escitalopram in psychogenic excoriation.
    Pukadan D; Antony J; Mohandas E; Cyriac M; Smith G; Elias A
    Aust N Z J Psychiatry; 2008 May; 42(5):435-6. PubMed ID: 18499934
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.
    Montgomery SA; Huusom AK; Bothmer J
    Neuropsychobiology; 2004; 50(1):57-64. PubMed ID: 15179022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of desipramine toxicity with citalopram.
    Ashton AK
    J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
    [No Abstract]   [Full Text] [Related]  

  • 20. An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD).
    Rao V; Spiro JR; Rosenberg PB; Lee HB; Rosenblatt A; Lyketsos CG
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):273-4. PubMed ID: 16477587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.